ARCHIVES

Final Results from CLEOPATRA Phase III Trial Show Perjeta Increased OS 15.7 Months

This article is from The Cancer Letter archive.

Vol. 37 No. 9 | September 26, 2014

Download PDF Visit The Full Archive

Related Articles

Funding opportunities listed.

June 25, 2004

Retrospective Data Clean-up Can’t Help C225 Phase II Trial; Protocol Far Too “Fuzzy”

March 8, 2002

Funding opportunities listed.

February 13, 2004

FCRF Contracts Recompetition Will Be Along Same Lines As in 1982 But for at Least Seven Years

July 5, 1985

Modeling: Like The Sims But No Graphics

November 26, 2010

NCI Faces Major Cuts On Gramm-Rudman Sequestration; Grants, Centers, Trials Slashed

November 3, 1989